Publications by authors named "Simona Ferjan"

Claim this Profile
S
Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study.
Mojca Jensterle, Jernej Kovac, Andrej Vovk, Simona Ferjan, Saba Battelino

J Clin Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review.
Andrijana Koceva, Katarina Mlekuš Kozamernik, Andrej Janež, Rok Herman, Simona Ferjan

Front Endocrinol (Lausanne)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study.
Mojca Jensterle, Simona Ferjan, Andrej Janez

Front Endocrinol (Lausanne)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects.
Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež, Mojca Jensterle

Life (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity.
Mojca Jensterle, Simona Ferjan, Luka Ležaič, Aljaž Sočan, Katja Goričar

Diabetes Obes Metab· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study.
Mojca Jensterle, Simona Ferjan, Andrej Vovk, Tadej Battelino, Manfredi Rizzo

Diabetes Res Clin Pract· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial.
Mojca Jensterle, Simona Ferjan, Tadej Battelino, Jernej Kovač, Saba Battelino

Trials· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort.
Mojca Jensterle, Nika Aleksandra Kravos, Simona Ferjan, Katja Goricar, Vita Dolzan

Endocr Connect· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity.
Simona Ferjan, Mojca Jensterle, Tjasa Oblak, Irena Prodan Zitnik, Janja Marc

J Int Med Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
Simona Ferjan, Andrej Janez, Mojca Jensterle

Endocr Pract· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
Simona Ferjan, Andrej Janez, Mojca Jensterle

Metab Syndr Relat Disord· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis